Atlas Trials

Vaccinex Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vaccinex Inc.

RecordFirmDate
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma (NCT05102721)Vaccinex Inc.2022-12-10
Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT04815720)Vaccinex Inc.2021-08-09
SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) (NCT04381468)Vaccinex Inc.2021-07-22
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer (NCT03268057)Vaccinex Inc.2017-10-05

Track Vaccinex Inc. automatically

Every clearance here is in the API, with alerts when new ones post.